Li et al. [36] confirmed that overexpression of EGF receptor could enhance the phosphorylation of STAT3, and EGFR‐SRC‐STAT3 signaling results in resistance to sorafenib in HCC. This evidence concerns the gene STAT3 and hepatocellular carcinoma.